|Title:||Using 18F-FLT PET to distinguish between malignant and benign breast lesions with suspicious findings in mammography and breast ultrasound||Authors:||JANE WANG
TIFFANY TING-FANG SHIH
|Issue Date:||2014||Journal Volume:||28||Journal Issue:||10||Start page/Pages:||941-949||Source:||Annals of Nuclear Medicine||Abstract:||
Purpose: To investigate the diagnostic performance of 3′-deoxy-3′-[18F]fluorothymidine (18F-FLT) PET in women with suspicious breast findings on conventional imaging (mammography and breast ultrasound).Methods: Twenty-eight women with suspicious findings on conventional imaging were enrolled. A whole-body PET/CT in the supine position (first PET) was performed 60?min after intravenous injection of 0.07?mCi/kg 18F-FLT, followed by a regional PET of the breast in the prone position (second PET). For each lesion, the SUVmax of the first PET (SUV1) and second PET (SUV2) were measured. For the receiver operating characteristic (ROC) analysis of the diagnostic parameters, of the cutoff points with sensitivities >90?%, we chose the one with highest specificity as the optimal cutoff point to obtain the corresponding sensitivity and specificity.Results: A total of 34 breast lesions (21 benign, 13 malignant) were analyzed. The SUV1 and SUV2 of the malignant lesions (median values 4.6 vs. 4.4, respectively) were higher than those of the benign lesions that had medians of 1.2 and 1.0, respectively (P?=?0.0001). The area under the ROC curve (AUC) of SUV1 (0.905) showed no significant difference from that of SUV2 (0.912) (P?=?0.77). The sensitivity and specificity using SUV1?=?1.24 as cutoff were 92.3 and 52.4?%, and those using SUV2?=?1.5 as cutoff were 92.3 and 66.7?%, respectively.Conclusion: 18F-FLT PET showed acceptable diagnostic performance for suspicious breast findings on conventional imaging, and SUV2 showed higher specificity than SUV1. ? 2014, The Japanese Society of Nuclear Medicine.
|URI:||https://scholars.lib.ntu.edu.tw/handle/123456789/514458||ISSN:||0914-7187||DOI:||10.1007/s12149-014-0889-7||SDG/Keyword:||3' fluorothymidine f 18; 2',3' dideoxynucleoside derivative; 3' fluorothymidine; radiopharmaceutical agent; adult; aged; Article; aspiration cytology; breast biopsy; breast carcinoma; breast disease; breast fibroadenoma; breast papilloma; clinical article; computer assisted emission tomography; controlled study; diagnostic accuracy; diagnostic test accuracy study; diagnostic value; differential diagnosis; echomammography; female; fibrocystic breast disease; fine needle aspiration biopsy; histopathology; human; intraductal carcinoma; malignant neoplastic disease; mammography; positron emission tomography; predictive value; receiver operating characteristic; sensitivity and specificity; body posture; breast; Breast Neoplasms; computer assisted tomography; diagnostic use; echomammography; mammography; middle aged; multimodal imaging; positron emission tomography; procedures; prospective study; scintiscanning; supine position; whole body imaging; Adult; Aged; Breast; Breast Neoplasms; Dideoxynucleosides; Female; Humans; Mammography; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prone Position; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Supine Position; Tomography, X-Ray Computed; Ultrasonography, Mammary; Whole Body Imaging
|Appears in Collections:||醫學院附設醫院 (臺大醫院)|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.